Integrated Modules Analysis to Explore the Molecular Mechanisms of Phlegm-Stasis Cementation Syndrome with Ischemic Heart Disease

Abstract

Background: Ischemic heart disease (IHD) has been the leading cause of death for several decades globally, IHD patients usually hold the symptoms of phlegm-stasis cementation syndrome (PSCS) as significant complications. However, the underlying molecular mechanisms of PSCS complicated with IHD have not yet been fully elucidated.Materials and Methods: Network medicine methods were utilized to elucidate the underlying molecular mechanisms of IHD phenotypes. Firstly, high-quality IHD-associated genes from both human curated disease-gene association database and biomedical literatures were integrated. Secondly, the IHD disease modules were obtained by dissecting the protein-protein interaction (PPI) topological modules in the String V9.1 database and the mapping of IHD-associated genes to the PPI topological modules. After that, molecular functional analyses (e.g., Gene Ontology and pathway enrichment analyses) for these IHD disease modules were conducted. Finally, the PSCS syndrome modules were identified by mapping the PSCS related symptom-genes to the IHD disease modules, which were further validated by both pharmacological and physiological evidences derived from published literatures.Results: The total of 1,056 high-quality IHD-associated genes were integrated and evaluated. In addition, eight IHD disease modules (the PPI sub-networks significantly relevant to IHD) were identified, in which two disease modules were relevant to PSCS syndrome (i.e., two PSCS syndrome modules). These two modules had enriched pathways on Toll-like receptor signaling pathway (hsa04620) and Renin-angiotensin system (hsa04614), with the molecular functions of angiotensin maturation (GO:0002003) and response to bacterium (GO:0009617), which had been validated by classical Chinese herbal formulas-related targets, IHD-related drug targets, and the phenotype features derived from human phenotype ontology (HPO) and published biomedical literatures.Conclusion: A network medicine-based approach was proposed to identify the underlying molecular modules of PSCS complicated with IHD, which could be used for interpreting the pharmacological mechanisms of well-established Chinese herbal formulas (e.g., Tao Hong Si Wu Tang, Dan Shen Yin, Hunag Lian Wen Dan Tang and Gua Lou Xie Bai Ban Xia Tang). In addition, these results delivered novel understandings of the molecular network mechanisms of IHD phenotype subtypes with PSCS complications, which would be both insightful for IHD precision medicine and the integration of disease and TCM syndrome diagnoses.

<p>A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus</p>

“…KEGG pathway analysis was performed to further probe the vital biological process of achieved targets and to validate the reliability of the integrated results 31–33. Finally, KEGG ( http://www.genome.ad.jp/kegg/ , updated February 1, 2019) terms with p -value ≤ 0.05 were selected for further research.…”

A network pharmacology approach to determine the underlying mechanisms of action of Yishen Tongluo formula for the treatment of oligoasthenozoospermia

“…To further clarify the molecular mechanism of YSTLF in oligoasthenozoospermia treatment, Cytoscape 3.7.2 was applied to establish a disease-formula-compound-target-pathway network [ 26 ]. In this graphical network, the disease, formula, compounds, targets and pathways were expressed as nodes, whereas the disease-formula-compound-target-pathway interactions were expressed as edges.…”

Characterization of chemical profile and quantification of major representative components of Wendan decoction, a classical traditional Chinese medicine formula

“…Traditional Chinese Medicine (TCM) prescriptions have attracted more and more attention all over the world owing to the reliable clinical effect in the prevention and treatment of complex and chronic diseases [1]. Wendan decoction (WDD), a classical TCM formula, initially recorded in Ji Yan Fang in the Southern and Northern Dynasties, has been widely used for the treatment of phlegm syndrome closely related to cardiovascular disease for thousands of years [2, 3]. In addition, it can also cure anxiety disorder [4], depression [5], Alzheimer's disease [6], and metabolic syndrome [7].…”